Economics ❯ Healthcare Economics

Cost Reduction

Consumer Savings International Pricing Consumer Impact Medicare Savings Prescription Drug Costs Public Health Government Spending Insurance Costs Pharmaceutical Industry Innovation in Healthcare Pharmaceutical Agreements Tariffs Therapy Services Importation Impact Negotiated Prices Budget Efficiency Government Initiatives Insurance Premiums Insurance Coverage Affordable Medicines Efficiency in Healthcare Market Competition Pharmaceuticals Insurance Models Patient Access Consumer Pricing Insurance Policies Insurance Programs Healthcare Spending Insurance Impact Budgeting Public Funding Market Comparison Pharmaceutical Economics Subsidy Programs Spending Cuts Government Deals Public Health Spending Healthcare Affordability Healthcare Services Healthcare Expenditure Healthcare Funding Drug Affordability Consumer Access Pharmaceutical Costs Consumer Behavior

Yale Preprint Says Medicare for All Could Save 114,000 Lives and $1 Trillion a Year

The unreviewed model attributes most savings to lower drug prices with reduced administrative and fraudulent billing costs as a key secondary driver.

Senate Health Panel Advances Bipartisan Hospital Price‑Transparency Bill

FDA Approves Colorado Plan to Import 20 Prescription Drugs From Canada

Supreme Court Rejects Drugmakers’ Appeals Over Medicare Price Talks

House Oversight Hearing Weighs Tech Fixes for Soaring Health Costs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026